Read More Healthcare Industry News Saluda Medical wins CAP24 FDA approval as ASX:SLD shares rally 22% Discover how Saluda Medical’s CAP24 FDA approval may expand Evoke adoption, reshape SCS competition and test ASX’s execution. Read the analysis in full. byVenkateshJune 30, 2026